Pharming (PHAR) Long-Term Investments (2019 - 2026)
Pharming (PHAR) reported Long-Term Investments of $2.06 million for Q2 2026, up 104.3% from $1.01 million a year earlier and up 34.1% from the prior quarter.
Pharming (PHAR) Long-Term Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharming posted Long-Term Investments of $1.94 million, up 317.2% from FY2024.
- Long-Term Investments has a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
- By year, Long-Term Investments came in at $466,000 in FY2024 (-79.6%), $2.29 million in FY2023 (-8.6%), $2.5 million in FY2022 (-65.3%) and $7.2 million in FY2021 (+1.2%).
- The Q2 2026 figure ranks as the highest quarterly Long-Term Investments since Q2 2023.
- Year over year, Long-Term Investments has now increased in each of the last three quarters, with growth averaging 60.8% over the last seven quarters.
- The high point for year-over-year Long-Term Investments in five years was Q4 2025 (growth of 317.2%); the low point was Q3 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.53 million (Q1 2026), $1.94 million (Q4 2025) and $1.01 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Pharming | 700.98 Mn | -129.18 Mn | 141.47 Mn | 2.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.06 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 672,000.00 |
| Dec 31, 2024 | 466,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | 2,845.00 |
| Jun 30, 2022 | 3.14 Mn |
| Mar 31, 2022 | 6.63 Mn |
| Dec 31, 2021 | 7,267.65 |
| Sep 30, 2021 | 7.19 Mn |
| Jun 30, 2021 | 7.26 Mn |
Pharming Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=PHAR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();